The IFT172 gene helps build and maintain cilia, the tiny hairlike structures that let cells sense signals and move fluid. If it does not work properly, these cell structures may not form or function well, which can affect vision, brain development, kidney function, and bone growth. The protein made by this gene helps your cells respond to important growth signals, especially during early development. Pathogenic variants in the IFT172 gene are linked to a group of conditions called ciliopathies, including some inherited retinal conditions and some skeletal conditions.
What is a gene?
Within DNA, genes are sections that store information your cells can use either to make molecules or to regulate processes in the body. In some cases, that information is used to produce proteins, the working parts of cells. In others, the main role is to control when certain processes happen, where they happen, and how strongly they operate. Altogether, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
IFT172Gene function
What if the gene works
The IFT172 gene helps cells build and maintain cilia, the tiny hairlike structures that sense signals and move fluid. Its protein supports transport within cilia, which is important for development and the normal function of several organs.
Risk
What if the gene does not work
Variants in the IFT172 gene can cause ciliopathies, ranging from isolated retinal disease to broader conditions affecting bone growth, kidneys, and brain development. Milder and more severe variants can influence which features appear and how early they begin.
Treatment
What does that mean for your treatment
No IFT172-specific treatment or drug choice is currently established for pathogenic variants in the IFT172 gene. Care is guided by the symptoms and organs involved rather than by the gene change itself.
Conditions associated with IFT172
Gene function
What if the gene works
Many cells depend on tiny surface structures called cilia to sense their surroundings and coordinate routine signals. The IFT172 gene helps build and run these structures by supporting the movement of materials inside them. When it works properly, cilia can grow, stay organized, and pass along signals that guide everyday cell activity.
The IFT172 gene helps cells form cilia, which are tiny projections on the cell surface. These structures act like small sensors and help cells stay organized.
Inside cilia, the IFT172 gene supports a delivery system that moves proteins and other materials to the right place. This steady flow helps cilia grow, renew themselves, and keep their shape.
By keeping cilia working smoothly, the IFT172 gene helps cells receive and relay signals that guide growth and body organization. This is a key part of how the IFT172 gene supports normal cilia function in the body.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change a gene’s function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many IFT172 gene variants change the shape or stability of the IFT172 protein, so it cannot move materials properly within cilia (tiny hair-like cell structures). Some variants leave partial activity, while more severe variants can sharply reduce or stop protein function, often by making the protein too short or unstable. This range helps explain why IFT172 gene variants may be linked to milder changes affecting mainly the eyes in some people and earlier, broader ciliopathy features in others.
How variants are linked to conditions
Pathogenic variants in the IFT172 gene cause a group of inherited conditions called ciliopathies. Among the best-established conditions linked to variants in the IFT172 gene are Mainzer-Saldino syndrome, short-rib thoracic dysplasia, and some inherited retinal diseases such as retinitis pigmentosa. Some people mainly have vision loss, while others also have kidney findings, changes in bone growth, or differences in brain development.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely seen in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the IFT172 gene. In families with a disease-causing IFT172 change, risk is mainly shaped by the inherited variant itself rather than lifestyle, and a doctor or genetic counselor can help explain personal and family risk.
Inheritance of IFT172 variants
IFT172-related conditions are inherited in an autosomal recessive pattern. This means a person usually needs to inherit two disease-causing variants in the IFT172 gene, one from each parent, to have the condition. Parents who each carry one variant are often unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. In practical terms, IFT172 inheritance means the gene change can be passed to sons and daughters equally.
What does my IFT172 result mean for my family?
IFT172 results can mean different things for relatives because this gene is linked to more than one inherited condition. In many families, parents and siblings may be carriers of a recessive IFT172 change even if they do not have symptoms, while in the rarer dominant form, close relatives may also carry the variant and could be affected. What this means for your family depends on which IFT172 condition and variant were found.
Genetic information
Genetic testing
How you find out about variants
IFT172 genetic testing uses a blood or saliva sample to look for variants, often through a multigene panel or exome sequencing when doctors suspect an inherited condition affecting the eyes, kidneys, or several body systems. Results can show whether one or both copies of the IFT172 gene carry a variant, although some findings remain uncertain.
When should I consider getting a genetic test?
Consider testing for IFT172 if you or your child has signs of an inherited condition affecting the eyes, kidneys, or bone growth, especially early vision loss, extra fingers or toes, or a family history of similar problems. Testing can help confirm whether a change in IFT172 is the cause.
A genetic result is only one part of your health story
A genetic result can provide useful information, but how much it reveals varies based on the condition and the kind of variant involved. Over time, many factors, including age, lifestyle, environment, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for some people, has less effect in others, or causes more side effects in some than in others.
What is Pharmacogenetics?
The field of pharmacogenetics examines how genetic variation can shape a person’s response to medications. It looks at connections between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment choices that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the IFT172 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so any concerns about symptoms, treatment, or medicine side effects are best discussed with your doctor or pharmacist.
History
Researchers identified the IFT172 gene during studies of tiny cell structures called cilia, first in model organisms and later in people. In recent decades, awareness of this gene’s role has grown as scientists linked changes in IFT172 to a group of inherited conditions affecting growth, vision, and brain development. Early work on intraflagellar transport, the system that moves materials within cilia, helped place IFT172 among the key genes in this pathway. Building on this early work, scientists uncovered more about the gene through families with ciliopathies, a name for conditions caused by problems with cilia. These findings helped connect basic laboratory research with genetic testing used in clinical care today.